Search Results
Sean Pittock, ECTRIMS 2022: Phase 3 CHAMPION-NMOSD trial results – Ravulizumab for AQP4-IgG NMOSD
Sean Pittock, EAN 2020 – Phase 3 PREVENT Study Insights in Neuromyelitis Optica Spectrum Disorder
Zero Relapses in Patients With NMOSD Given Ravulizumab
Bruce Cree – ECTRIMS 2022
Potential for Preventing NMOSD, Improving Access to Panel Testing
Racial disparities among patients with NMOSD
8th Joint ACTRIMS-ECTRIMS Meeting: Poster Presentation Dr. Robert Fox
NVJC Ep. 46 Multiple Sclerosis/Autoimmune Neurology: Differentiating MS From AAQP4-NMOSD & MOGAD
Professor "Chip" Howard patient story
2023 NMOSD Together | Live Q&A Session
6th Annual TSF Gala | Michael Levy, MD, PhD
Key updates and research focuses at ECTRIMS 2022
